机译:单独的体外光疗法和类固醇的随机期II试验单独用于新诊断的急性GVHD
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Biostat Canc Ctr Houston TX USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Utah Huntsman Canc Ctr Salt Lake City UT USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
Univ Texas Houston Dept Stem Cell Transplantat &
Cellular Therapy Canc Ctr Houston TX 77021 USA;
机译:与单独使用大剂量类固醇相比,用OKT3和大剂量类固醇治疗对类固醇耐药的急性GVHD可以更好地控制疾病并降低感染并发症的发生率:EBMT慢性白血病工作组进行的一项随机多中心试验
机译:类固醇/霉酚酸酯与类固醇/安慰剂治疗急性GVHD的3期临床试验:BMT CTN 0802
机译:ruxolitinib在GVHD(钻机)研究:多中心,随机阶段2试验,以确定罗尾蛋白和最佳可用治疗(BAT)与蝙蝠在类固醇耐火急性移植物 - 宿主病(AGVHD)中的响应率(NCT02396628)
机译:风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松,用于新诊断的未经治疗的全身淀粉样蛋白症患者:II期试验的中期报告
机译:鱼油(二十碳五烯酸和二十二碳六烯酸)对急性肺损伤患者的肺和全身炎症的II期,随机,双盲,安慰剂对照试验。
机译:类固醇/霉酚酸酯与类固醇/安慰剂治疗急性GVHD的3期临床试验:BMT CTN 0802
机译:类固醇/安慰剂对比的多中心,随机,双盲,III期临床试验。类固醇/霉酚酸酯作为急性移植物抗宿主病的初始疗法。血液和骨髓移植临床试验网络研究0802
机译:随机临床试验评估新诊断乳腺癌患者的高级护理